QDM PE Ratio 2010-2023 | QDMI
Current and historical p/e ratio for QDM (QDMI) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. QDM PE ratio as of May 07, 2024 is 18.40.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| QDM PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 0.00 | nan | ||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.703B | $0.001B |
| QDM International Inc. is a telemedicine company which operates principally in Florida and Georgia. It provides Connect-a-Doc telemedicine kits which include digital otoscope, stethoscope, blood pressure cuff, thermometer and high definition, and dental and dermatology cameras for schools, desire to provide healthcare to their students but are unable to keep a full time school nurse available. QDM International Inc., formerly known as 24/7 Kid Doc Inc., is based in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.615B | 15.64 |
| Cencora (COR) | United States | $45.231B | 17.63 |
| ICON (ICLR) | Ireland | $25.948B | 24.50 |
| DiDi Global (DIDIY) | China | $24.059B | 0.00 |
| Avantor (AVTR) | United States | $16.880B | 24.85 |
| CochLear (CHEOY) | Australia | $14.219B | 0.00 |
| Viatris (VTRS) | United States | $13.955B | 4.01 |
| Revvity (RVTY) | United States | $12.744B | 22.33 |
| Medpace Holdings (MEDP) | United States | $12.458B | 40.99 |
| Charles River Laboratories (CRL) | United States | $12.172B | 22.19 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.058B | 0.00 |
| Natera (NTRA) | United States | $11.732B | 0.00 |
| Solventum (SOLV) | United States | $11.310B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.460B | 0.00 |
| HealthEquity (HQY) | United States | $6.897B | 51.53 |
| Organon (OGN) | United States | $5.246B | 4.98 |
| Bausch + Lomb (BLCO) | Canada | $5.236B | 20.99 |
| Doximity (DOCS) | United States | $4.546B | 33.85 |
| PACS (PACS) | United States | $3.752B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.530B | 32.29 |
| Sotera Health (SHC) | United States | $3.247B | 15.93 |
| Progyny (PGNY) | United States | $3.177B | 53.32 |
| GoodRx Holdings (GDRX) | United States | $2.974B | 150.60 |
| Life Times (LTH) | United States | $2.968B | 31.44 |
| Premier (PINC) | United States | $2.326B | 8.70 |
| AMN Healthcare Services Inc (AMN) | United States | $2.281B | 7.38 |
| Teladoc Health (TDOC) | United States | $2.184B | 0.00 |
| Agilon Health (AGL) | United States | $2.047B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.967B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.671B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.481B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.314B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 8.08 |
| Embecta (EMBC) | United States | $0.607B | 4.01 |
| InnovAge Holding (INNV) | United States | $0.579B | 0.00 |
| CareDx (CDNA) | United States | $0.543B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.529B | 0.00 |
| LifeMD (LFMD) | United States | $0.506B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.504B | 0.00 |
| Enhabit (EHAB) | United States | $0.497B | 45.00 |
| Auna S.A (AUNA) | Luxembourg | $0.493B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.416B | 0.00 |
| ModivCare (MODV) | United States | $0.374B | 7.00 |
| DocGo (DCGO) | United States | $0.371B | 59.33 |
| Sera Prognostics (SERA) | United States | $0.307B | 0.00 |
| Sharecare (SHCR) | United States | $0.263B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.178B | 0.00 |
| So-Young (SY) | China | $0.129B | 43.17 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.066B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.036B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |